CompletedNCT02532842
Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate
Observational studyAges 18–29Multiple countries
Understand this study
Who was this study for?
Listed age limits: 18 years to 29 years.
- Listed locations
- Rijeka and 6 more locationsSee all locations and recruitment
Study information
Study start dateJuly 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 90
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- Croatia, Russia, Türkiye
- Age range
- From 18 Years to 29 Years
- Official registry ID
- NCT02532842
- Official title
Show the full official title
Paliperidone Palmitate in Early Schizophrenia - A Retrospective, Non-interventional Study of Patients With Newly Diagnosed Schizophrenia Treated With Paliperidone Palmitate Over a 12-Month Period
Get this study by email
Recruitment & locations
CompletedRijeka, Croatia · Split, Croatia · Zagreb, Croatia
6 more locations
- Moscow, Russia
- Saint Petersburg, Russia
- Ankara, Türkiye
- Denizli, Türkiye
- Russia
- Türkiye
Questions about this study
Who is behind this study?
The study sponsor is Janssen Pharmaceutica N.V., Belgium.
Who was this study for?
Listed age limits: 18 years to 29 years.
